Sorrento Therapeutics (SRNE)

Sorrento Therapeutics (SRNE) Stock Price & Analysis


SRNE Stock Chart & Stats

Day’s Range$0.26 - $0.4735
52-Week Range― - ―
Previous Close$0.39
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding547,880,267
10 Day Avg. Volume116,832,490
30 Day Avg. Volume46,956,518
Standard Deviation0.36
Financial Highlights & Ratios
Price to Book (P/B)-1.42
Price to Sales (P/S)3.60
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside4130.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Sorrento Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Sorrento Therapeutics’s market cap?
Currently, no data Available
When is Sorrento Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sorrento Therapeutics’s earnings last quarter?
Currently, no data Available
Is Sorrento Therapeutics overvalued?
According to Wall Street analysts Sorrento Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Sorrento Therapeutics pay dividends?
    Sorrento Therapeutics does not currently pay dividends.
    What is Sorrento Therapeutics’s EPS estimate?
    Sorrento Therapeutics’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Sorrento Therapeutics have?
    Currently, no data Available
    What happened to Sorrento Therapeutics’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Sorrento Therapeutics?
    Among the largest hedge funds holding Sorrento Therapeutics’s share is Graham Capital Management, L.P.. It holds Sorrento Therapeutics’s shares valued at 12K.


      Sorrento Therapeutics Stock Smart Score

      The Sorrento Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
      Learn more about TipRanks Smart Score

      Company Description

      Sorrento Therapeutics

      Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Avidity Biosciences
      HilleVax, Inc
      Century Therapeutics

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis